CD9 and asthma: Furthermore, a CD39+CD9+ lung interstitial macrophage identified in neutrophil-dominant asthma mitigates IL-23/Th17-mediated neutrophilic inflammation through CD9-dependent neutrophil adhesion and CD39-dependent ATP hydrolysis [181].